107 related articles for article (PubMed ID: 3125389)
1. Protective mechanism of the immune response to a ribosomal vaccine from Pseudomonas aeruginosa. II. In vitro bactericidal and opsonophagocytic studies with specific antiserum.
Lieberman MM; Frank WJ; Brady AV
J Surg Res; 1988 Mar; 44(3):251-8. PubMed ID: 3125389
[TBL] [Abstract][Full Text] [Related]
2. Opsonic activity of antisera to ribosomal vaccine fractions with live and formalinized Pseudomonas aeruginosa.
Lieberman MM; Allen RC
Can J Microbiol; 1986 Jun; 32(6):531-3. PubMed ID: 3089571
[TBL] [Abstract][Full Text] [Related]
3. Protective mechanism of the immune response to a ribosomal vaccine from Pseudomonas aeruginosa. I. In vivo protection studies in compromised animal models.
Lieberman MM; Frank WJ
J Surg Res; 1988 Mar; 44(3):242-50. PubMed ID: 3125388
[TBL] [Abstract][Full Text] [Related]
4. Immunologic investigations of mucoid strains of Pseudomonas aeruginosa: comparison of susceptibility to opsonic antibody in mucoid and nonmucoid strains.
Baltimore RS; Mitchell M
J Infect Dis; 1980 Feb; 141(2):238-47. PubMed ID: 6444976
[TBL] [Abstract][Full Text] [Related]
5. Opsonophagocytic killing activity of rabbit antibody to Pseudomonas aeruginosa mucoid exopolysaccharide.
Ames P; DesJardins D; Pier GB
Infect Immun; 1985 Aug; 49(2):281-5. PubMed ID: 3160660
[TBL] [Abstract][Full Text] [Related]
6. Phagocytosis and killing of Pseudomonas aeruginosa by mouse polymorphonuclear leukocytes in vitro promoted by antiserum to the slime glycolipoprotein.
Bishop O; Orr T; Bartell PF
Infect Immun; 1982 Jul; 37(1):378-81. PubMed ID: 6809634
[TBL] [Abstract][Full Text] [Related]
7. Serum bactericidal activity and phagocytosis in host defence against Haemophilus ducreyi.
Lagergård T; Frisk A; Purvèn M; Nilsson LA
Microb Pathog; 1995 Jan; 18(1):37-51. PubMed ID: 7783597
[TBL] [Abstract][Full Text] [Related]
8. Influence of different immunoglobulin G preparations on phagocytosis of Pseudomonas aeruginosa by polymorphonuclear granulocytes.
Trautmann M; Triest K; Hofstaetter T; Seiler FR; Hahn H
Zentralbl Bakteriol Mikrobiol Hyg A; 1985 Feb; 259(1):104-17. PubMed ID: 3923732
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the human immune response to a polysaccharide vaccine from Pseudomonas aeruginosa.
Pier GB; Thomas DM
J Infect Dis; 1983 Aug; 148(2):206-13. PubMed ID: 6411830
[TBL] [Abstract][Full Text] [Related]
10. Contribution of humoral and cellular factors to the resistance to experimental infection by Pseudomonas aeruginosa in mice. II. Opsonic, agglutinative, and protective capacities of immunoglobulin G anti-Pseudomonas antibodies.
Bjornson AB; Michael JG
Infect Immun; 1972 May; 5(5):775-82. PubMed ID: 4629252
[TBL] [Abstract][Full Text] [Related]
11. Passive immunization against Pseudomonas with a ribosomal vaccine-induced immune serum and immunoglobulin fractions.
Lieberman MM; McKissock DC; Wright GL
Infect Immun; 1979 Feb; 23(2):509-21. PubMed ID: 106013
[TBL] [Abstract][Full Text] [Related]
12. Production and characterization of a human hyperimmune intravenous immunoglobulin against Pseudomonas aeruginosa and Klebsiella species.
Cryz SJ; Fürer E; Sadoff JC; Fredeking T; Que JU; Cross AS
J Infect Dis; 1991 May; 163(5):1055-61. PubMed ID: 1902245
[TBL] [Abstract][Full Text] [Related]
13. Opsonic activity of specific human IgG against Helicobacter pylori.
Tosi MF; Czinn SJ
J Infect Dis; 1990 Jul; 162(1):156-62. PubMed ID: 2355192
[TBL] [Abstract][Full Text] [Related]
14. A quantitative method for assessing the third complement factor (C3) attached to the surface of opsonized Pseudomonas aeruginosa: interrelationship between C3 fixation, phagocytosis and complement consumption.
Engels W; Endert J; Van Boven CP
J Immunol Methods; 1985 Jul; 81(1):43-53. PubMed ID: 3926902
[TBL] [Abstract][Full Text] [Related]
15. Opsonization and phagocytosis of mucoid and non-mucoid Pseudomonas aeruginosa strains.
Meshulam T; Verbrugh HA; Verhoef J
Eur J Clin Microbiol; 1982 Apr; 1(2):112-7. PubMed ID: 6816585
[TBL] [Abstract][Full Text] [Related]
16. Complement-mediated phagocytosis of Pseudomonas aeruginosa.
Peterson PK; Kim Y; Schmeling D; Lindemann M; Verhoef J; Quie PG
J Lab Clin Med; 1978 Dec; 92(6):883-94. PubMed ID: 105067
[TBL] [Abstract][Full Text] [Related]
17. Quantitation of in vitro opsonic activity of human antibody induced by a vaccine consisting of the type III-specific polysaccharide of group B streptococcus.
De Cueninck BJ; Eisenstein TK; McIntosh TS; Shockman GD; Swenson RM
Infect Immun; 1983 Mar; 39(3):1155-60. PubMed ID: 6341229
[TBL] [Abstract][Full Text] [Related]
18. Factors in human serum promoting phagocytosis of Pseudomonas aeruginosa. I. Interaction of opsonins with the bacterium.
Bjornson AB; Michael JG
J Infect Dis; 1974 Nov; 130 Suppl(0):S119-26. PubMed ID: 4214223
[No Abstract] [Full Text] [Related]
19. Immunization of burn-patients with a Pseudomonas aeruginosa outer membrane protein vaccine elicits antibodies with protective efficacy.
Lee NG; Jung SB; Ahn BY; Kim YH; Kim JJ; Kim DK; Kim IS; Yoon SM; Nam SW; Kim HS; Park WJ
Vaccine; 2000 Mar; 18(18):1952-61. PubMed ID: 10699346
[TBL] [Abstract][Full Text] [Related]
20. Kinetic studies of phagocytosis. III. The complement-dependent opsonic and anti-opsonic effects of normal and sle sera.
Håkansson L; Hällgren R; Venge P
Immunology; 1982 Sep; 47(1):91-9. PubMed ID: 6981589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
